Small Molecules
3 January 2013
EnVivo Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial Program of EVP-0962 in Alzheimer’s Disease3 January 2013
Celtaxsys Initiates Phase 1 Study of CTX-4430 Oral Treatment for Pulmonary InflammationNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports